NASDAQ: APVO
Aptevo Therapeutics Inc Stock Ownership - Who owns Aptevo Therapeutics?

Insider buying vs selling

Have Aptevo Therapeutics Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when APVO insiders and whales buy or sell their stock.

APVO Shareholders

What type of owners hold Aptevo Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fuad Elhibri745.29%3,021,899$9.10MInsider
Scott C. Stromatt53.32%216,183$650.71kInsider
Jane A. Gross27.03%109,583$329.84kInsider
Shawnte Mitchell19.86%80,527$242.39kInsider
Randy Joe Maddux18.50%75,000$225.75kInsider
Michael Adelman17.37%70,426$211.98kInsider
Geode Capital Management LLC2.60%10,526$31.68kInstitution
Tower Research Capital LLC Trc0.80%3,255$9.80kInstitution
Clear Street LLC0.69%2,800$8.43kInstitution
Bank Of America Corp0.57%2,318$6.98kInstitution

1 of 3

APVO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
APVO0.55%99.45%
OGEN0.68%99.32%Net SellingNet Selling
REVB0.10%99.90%Net Buying
TNFA1.39%51.39%
SLRX0.55%99.45%

Aptevo Therapeutics Stock Ownership FAQ

Who owns Aptevo Therapeutics?

Aptevo Therapeutics (NASDAQ: APVO) is owned by 4.84% institutional shareholders, 881.69% Aptevo Therapeutics insiders, and 0.00% retail investors. Fuad Elhibri is the largest individual Aptevo Therapeutics shareholder, owning 3.02M shares representing 745.29% of the company. Fuad Elhibri's Aptevo Therapeutics shares are currently valued at $9.07M.

If you're new to stock investing, here's how to buy Aptevo Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.